Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Boguniewicz

Showing results (91-100 of 160) with videos related to

Pageof 16
Sort By:
BMC Dermatology|November 7, 2019
Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitisEric Simpson, Laurent Eckert, Abhijit Gadkari, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 10, 2018
Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adultsJonathan I Silverberg, Zelma C Chiesa Fuxench, Joel M Gelfand, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 23, 2019
Pain Is a Common and Burdensome Symptom of Atopic Dermatitis in United States AdultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
The Journal of Investigative Dermatology|April 23, 2019
Validation and Interpretation of Short Form 12 and Comparison with Dermatology Life Quality Index in Atopic Dermatitis in AdultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
The Journal of Investigative Dermatology|February 25, 2011
TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrierByung Eui Kim, Michael D Howell, Emma Guttman-Yassky, et al.
The Journal of Investigative Dermatology|December 21, 2018
Measurement Properties of the Hospital Anxiety and Depression Scale Used in Atopic Dermatitis in AdultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 21, 2018
Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional studyJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 10, 2018
Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
Journal of Pediatrics. Clinical Practice|February 14, 2025
Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group ConsensusMark Boguniewicz, Moise L Levy, Lawrence F Eichenfield, et al.
The Journal of Dermatological Treatment|August 30, 2008
Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adultsWilliam Abramovits, Adelaide A Hebert, Mark Boguniewicz, et al.
Pageof 16

Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
BMC Dermatology|November 7, 2019
Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitisEric Simpson, Laurent Eckert, Abhijit Gadkari, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 10, 2018
Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adultsJonathan I Silverberg, Zelma C Chiesa Fuxench, Joel M Gelfand, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 23, 2019
Pain Is a Common and Burdensome Symptom of Atopic Dermatitis in United States AdultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
The Journal of Investigative Dermatology|April 23, 2019
Validation and Interpretation of Short Form 12 and Comparison with Dermatology Life Quality Index in Atopic Dermatitis in AdultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
The Journal of Investigative Dermatology|February 25, 2011
TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrierByung Eui Kim, Michael D Howell, Emma Guttman-Yassky, et al.
The Journal of Investigative Dermatology|December 21, 2018
Measurement Properties of the Hospital Anxiety and Depression Scale Used in Atopic Dermatitis in AdultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 21, 2018
Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional studyJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 10, 2018
Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
Journal of Pediatrics. Clinical Practice|February 14, 2025
Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group ConsensusMark Boguniewicz, Moise L Levy, Lawrence F Eichenfield, et al.
The Journal of Dermatological Treatment|August 30, 2008
Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adultsWilliam Abramovits, Adelaide A Hebert, Mark Boguniewicz, et al.
Pageof 16